Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185939 · ClinicalTrials.gov registry record · Phase 2
The Use of Prophylactic Antibiotics In the Management of Dog Bites
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 125
- Enrollment target
NCT00185939: Completed Phase 2 study, sponsored by Stanford University.
NCT00185939 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185939, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 125 participants
- Enrollment target
Study Summary
This double blinded RCT will help to ascertain the usefulness of prophylactic antibiotics in the management of uncomplicated dog bites, utilizing currently best available antibiotics (Augmentin) and an important clinical outcome of infection. By enrolling 100-150 patients in this pilot trial as part of a k-award the investigators plan to utilize the point estimates of infection, side effects and other important outcomes and incorporate these into a cost most to determine the most cost effective management of these wounds and to determine if further study is warranted based on the findings.
Interventions
- DRUG Augmentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2003-08 |
| Est. Completion | 2005-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00185939
The ClinicalTrials.gov registry entry for NCT00185939 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Augmentin is the first listed.
NCT00185939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00185939 about?
NCT00185939 is a clinical study titled "The Use of Prophylactic Antibiotics In the Management of Dog Bites". This double blinded RCT will help to ascertain the usefulness of prophylactic antibiotics in the management of uncomplicated dog bites, utilizing currently best available antibiotics (Augmentin) and an important clinical outcome of infection. By enrolling 100-150 patients in this pilot trial as par...
What is the current status of trial NCT00185939?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 125 participants. The study started on 2003-08. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00185939?
The interventions under investigation include: Augmentin (DRUG).
Who is sponsoring clinical trial NCT00185939?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.